Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile

Lipids in Health and Disease

Volumn 13, Issue 1, 2014, Pages

  Corey, Kathleen E ^a,b,c   Misdraji, Joseph ^a,c   Gelrud, Lou ^c   Zheng, Hui ^a,c   Chung, Raymond T ^a,c   Krauss, Ronald M ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Bon Secours Richmond Health System   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Ion mobility analysis; Lipid subfractions; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN 2B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERMEDIATE DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN 2; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN IVB; UNCLASSIFIED DRUG; LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; ION MOBILITY SPECTROMETRY; LIPOPROTEIN SUBFRACTION PROFILE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; LIVER SURGERY; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN ANALYSIS; WEIGHT REDUCTION; ATHEROSCLEROSIS; BLOOD; MIDDLE AGED;

ADULT; ATHEROSCLEROSIS; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84902746898     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-13-100     Document Type: Article

References (15)

1. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Targher G, Bertolini L, Rodella S, Tessari R, Zenari L, Lippi G, Arcaro G, Diabetes Care 2007 30 2119 2121 (Pubitemid 47219432)
2. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, Angulo P, Gastroenterology 2005 129 113 121 (Pubitemid 41002048)
3. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K, Ann Intern Med 2005 143 722 728
4. Decreased survival of subjects with elevated liver function tests during a 28-year follow-up. Soderberg C, Stal P, Askling J, Glaumann H, Lindberg G, Marmur J, Hultcrantz R, Hepatology 2010 51 595 602
5. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Ekstedt M, Franzen LE, Mathiesen UL, Thorelius L, Holmqvist M, Bodemar G, Kechagias S, Hepatology 2006 44 865 873 (Pubitemid 46489550)
6. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. Robinson JG, Wang S, Smith BJ, Jacobson TA, J Am Coll Cardiol 2009 53 316 322
7. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P, Atherosclerosis 2009 202 289 295
8. Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Arsenault BJ, Lemieux I, Despres JP, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM, Eur Heart J 2007 28 2770 2777 (Pubitemid 350135531)
9. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH, Reitz RE, Krauss RM, Clin Chem 2008 54 1307 1316
10. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Musunuru K, Orho-Melander M, Caulfield MP, Li S, Salameh WA, Reitz RE, Berglund G, Hedblad B, Engstrom G, Williams PT, Kathiresan S, Melander O, Krauss RM, Arterioscler Thromb Vasc Biol 2009 29 1975 1980
11. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ, Hepatology 2005 41 1313 1321 (Pubitemid 40770284)
12. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, Ratziu V, McCullough A, Hepatology 2011 54 344 353
13. Smallest LDL particles are most strongly related to coronary disease progression in men. Williams PT, Superko HR, Haskell WL, Alderman EL, Blanche PJ, Holl LG, Krauss RM, Arterioscler Thromb Vasc Biol 2003 23 314 321 (Pubitemid 36231946)
14. High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients. Johansson J, Carlson LA, Landou C, Hamsten A, Arterioscler Thromb 1991 11 174 182
15. The distribution of high-density lipoprotein subfractions in coronary survivors. Wilson HM, Patel JC, Skinner ER, Biochem Soc Trans 1990 18 1175 1176